Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Maria Mironova(National Institutes of Health), Maria F. Lopes‐Virella(Medical University of South Carolina), Richard L. Klein(AdventHealth Tampa), Gabriel Virella(Ralph H. Johnson VA Medical Center)
Cited by 97
Related Papers
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726
Prevention Conference VI: Diabetes and Cardiovascular Disease
|Circulation|2002|199
<i>Chlamydophila pneumoniae</i> Induces ICAM-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C–Dependent Activation of Nuclear Factor-κB
|Circulation Research|2003|33
Hepatitis B Vaccine: Four Decades on
|Vaccines|2024|26
Granulomatous liver diseases
|Hepatology Communications|2024|25